Guiqin Xu

State Key Laboratory Of Systems Medicine For Cancer
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Decorin facilitates T cell-mediated antitumor immunity and augments the efficacy of anti-PD1 immunotherapy.

Decorin facilitates T cell-mediated antitumor immunity and augments the efficacy of anti-PD1 immunotherapy.

Journal: Cancer immunology, immunotherapy : CII
Published: July 14, 2025

Targeting of COPⅠ elicits CD8+ T cell-mediated anti-tumor immunity and suppresses growth of intrahepatic cholangiocarcinoma.

Targeting of COPⅠ elicits CD8+ T cell-mediated anti-tumor immunity and suppresses growth of intrahepatic cholangiocarcinoma.

Journal: Cancer letters
Published: January 24, 2025

Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy.

Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy.

Journal: Science advances
Published: September 11, 2024

UBXN1 promotes liver tumorigenesis by regulating mitochondrial homeostasis.

UBXN1 promotes liver tumorigenesis by regulating mitochondrial homeostasis.

Journal: Journal of translational medicine
Published: December 21, 2023

UBXN9 inhibits the RNA exosome function to promote T cell control of liver tumorigenesis.

UBXN9 inhibits the RNA exosome function to promote T cell control of liver tumorigenesis.

Journal: Hepatology (Baltimore, Md.)
Published: May 17, 2023

Correction to: USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis.

Correction to: USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis.

Journal: Oncogene
Published: February 04, 2022

ETV4 potentiates nuclear YAP retention and activities to enhance the progression of hepatocellular carcinoma.

ETV4 potentiates nuclear YAP retention and activities to enhance the progression of hepatocellular carcinoma.

Journal: Cancer letters
Published: November 01, 2021

Deubiquitination of the repressor E2F6 by USP22 facilitates AKT activation and tumor growth in hepatocellular carcinoma.

Deubiquitination of the repressor E2F6 by USP22 facilitates AKT activation and tumor growth in hepatocellular carcinoma.

Journal: Cancer letters
Published: April 17, 2021

The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis.

The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis.

Journal: Oncogene
Published: February 20, 2021

USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade.

USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade.

Journal: Nature communications
Published: October 21, 2020

POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.

POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.

Journal: EBioMedicine
Published: October 09, 2018

Requirement for POH1 in differentiation and maintenance of regulatory T cells.

Requirement for POH1 in differentiation and maintenance of regulatory T cells.

Journal: Cell death and differentiation
Published: March 31, 2018
Showing 1-12 of 19

Last Updated: 09/26/2026